Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Clay

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Cancers|April 12, 2022
<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYCCarolyn M Jablonowski, Hyea Jin Gil, Emilia M Pinto, et al.
Science Translational Medicine|October 26, 2022
Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of <i>Subdoligranulum</i>Meagan E Chriswell, Adam R Lefferts, Michael R Clay, et al.
Nature Aging|May 25, 2023
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic mannerKate M Warde, Lorenzo J Smith, Lihua Liu, et al.
Molecular Cancer Therapeutics|August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging AgentsJessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Nature|August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumoursElizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Nature Communications|December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumorAndrew J Murphy, Xiang Chen, Emilia M Pinto, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Cancers|April 12, 2022
<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYCCarolyn M Jablonowski, Hyea Jin Gil, Emilia M Pinto, et al.
Science Translational Medicine|October 26, 2022
Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of <i>Subdoligranulum</i>Meagan E Chriswell, Adam R Lefferts, Michael R Clay, et al.
Nature Aging|May 25, 2023
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic mannerKate M Warde, Lorenzo J Smith, Lihua Liu, et al.
Molecular Cancer Therapeutics|August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging AgentsJessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Nature|August 31, 2017
Orthotopic patient-derived xenografts of paediatric solid tumoursElizabeth Stewart, Sara M Federico, Xiang Chen, et al.
Nature Communications|December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumorAndrew J Murphy, Xiang Chen, Emilia M Pinto, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Pageof 6